» Articles » PMID: 25687639

The Neuroprotective Effect of Glycyrrhizic Acid on an Experimental Model of Focal Cerebral Ischemia in Rats

Overview
Journal Inflammation
Date 2015 Feb 18
PMID 25687639
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral ischemia is still one of the most important topics in neurosciences. Our study aimed to investigate the neuroprotective and anti-oxidant effects of glycyrrhizic acid on focal cerebral ischemia in rats. Twenty-four rats were divided equally into three groups. A middle cerebral artery occlusion model was performed in this study where sham and glycyrrhizic acid were administered intraperitoneally following middle cerebral artery occlusion. Group I was evaluated as control. Malondialdehyde (MDA), superoxide dismutase (SOD), and nuclear respiratory factor-1 (NRF1) levels were analyzed biochemically on the right cerebral hemisphere, while ischemic histopathological studies were completed to investigate the anti-oxidant status. Biochemical results showed that SOD and NRF1 levels were significantly increased in the glycyrrhizic acid group compared with the sham group while MDA levels were significantly decreased. On histopathological examination, cerebral edema, vacuolization, degeneration, and destruction of neurons were decreased in the glycyrrhizic acid group compared with the sham group. Cerebral ischemia was attenuated by glycyrrhizic acid administration. These observations indicate that glycyrrhizic acid may have potential as a therapeutic agent in cerebral ischemia by preventing oxidative stress.

Citing Articles

Glycyrrhizic Acid Inhibits Hippocampal Neuron Apoptosis by Activating the PI3K/ AKT Signaling Pathway.

Fu G, Kang X, Lin S Biochem Genet. 2024; .

PMID: 39377899 DOI: 10.1007/s10528-024-10936-w.


Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid.

Ni Q, Gao Y, Yang X, Zhang Q, Guo B, Han J Front Pharmacol. 2022; 13:1001018.

PMID: 36313350 PMC: 9606671. DOI: 10.3389/fphar.2022.1001018.


High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice.

Ghosh D, Singh A, Kumar A, Sinha N Immunol Res. 2022; 70(5):633-643.

PMID: 35670903 DOI: 10.1007/s12026-022-09295-8.


Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy.

Guo Y, Zhang Y, Gao Y, Deng S, Wang L, Li C Front Pharmacol. 2021; 12:639651.

PMID: 34262447 PMC: 8273381. DOI: 10.3389/fphar.2021.639651.


Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.

Qiu Q, Huang Y, Liu X, Huang F, Li X, Cui L Front Pharmacol. 2020; 11:570893.

PMID: 33343347 PMC: 7741169. DOI: 10.3389/fphar.2020.570893.


References
1.
Cirak B, Rousan N, Kocak A, Palaoglu O, Palaoglu S, Kilic K . Melatonin as a free radical scavenger in experimental head trauma. Pediatr Neurosurg. 2000; 31(6):298-301. DOI: 10.1159/000028879. View

2.
Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, Brinker G . A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab. 1998; 18(4):367-75. DOI: 10.1097/00004647-199804000-00004. View

3.
Sun Y, Oberley L, Li Y . A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988; 34(3):497-500. View

4.
Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti M . Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J. 2008; 276(1):13-26. DOI: 10.1111/j.1742-4658.2008.06766.x. View

5.
Abas F, Alkan T, Goren B, Taskapilioglu O, Sarandol E, Tolunay S . Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats. Turk Neurosurg. 2010; 20(1):1-8. View